India healthcare PE/VC investment jumps 621% to $3.1 billion

By Amara Osei

India's healthcare sector attracted $3.1 billion in private equity and venture capital investment in Q3 2026, up 621% year on year and 878% quarter on quarter, according to EY-IVCA's latest monthly PE/VC roundup. The figure made healthcare the second-largest Indian sector by investment value during the quarter, EY-IVCA said.

EY-IVCA's roundup recorded 28 healthcare PE/VC transactions in Q3 2026, compared with 19 in Q2 2026. Activity rose across the quarter's three months: six deals in July, eight in August and 11 in September.

How strong was September?

PE/VC investment in healthcare reached $1.1 billion in September, 465% more than a year earlier, according to EY-IVCA. September generated 11 deals, the quarter's highest monthly count. July delivered six transactions, while August delivered eight, according to the monthly data.

What did the quarter-on-quarter comparison show?

EY-IVCA measured Q3 2026 investment value against Q2 2026 and reported an 878% increase. Its deal count moved in the same direction, from 19 transactions to 28. Healthcare's second-place ranking by investment value accompanied both more capital and more transactions than in the preceding quarter.

EY-IVCA also reported a 621% year-on-year increase in healthcare PE/VC investment for Q3 2026. Its monthly data separately recorded a 465% year-on-year rise for September, showing gains at both the quarterly and monthly levels.

EY-IVCA's figures use different measurement windows. The $3.1 billion and 28 deals cover Q3 2026; the $1.1 billion and 11 deals cover September. The 621% and 465% figures compare their respective periods with a year earlier, while 878% compares Q3 with Q2.

Which transaction led the quarter?

EY-IVCA identified KKR's $1.4 billion acquisition of Medicover India as the largest PE/VC transaction across all sectors during Q3 2026. The healthcare roundup included the period's largest PE/VC deal by value. Within healthcare's 28-deal quarter, KKR's Medicover India purchase ranked first by transaction value, according to EY-IVCA.

EY-IVCA's tables put the KKR-Medicover transaction at the top of the cross-sector ranking, while healthcare ranked second in aggregate sector value. The comparison separates one $1.4 billion deal from the $3.1 billion invested across 28 healthcare transactions.

What did healthcare exits show?

Healthcare ranked fifth among sectors by deal volume for PE/VC-backed IPO exits since 2021, EY-IVCA reported. It ranked third by exit value in Q3 2026, with $1.4 billion. The roundup thus placed healthcare's longer-term IPO exit count below four other sectors while placing its latest-quarter exit value among the top three.

The exit value equaled the value of KKR's Medicover India acquisition, although the two figures cover different measures: sectorwide IPO exit value and one corporate transaction. EY-IVCA's volume ranking reaches back to 2021, but its value ranking covers only Q3 2026. The two rankings therefore describe different time frames.

What does the data point to?

These measures answer different questions for investors. The $3.1 billion investment total covers PE/VC capital deployed in healthcare during Q3 2026, while the $1.4 billion exit value covers PE/VC-backed IPO exits during the same three-month period. EY-IVCA ranked the investment measure second by sector and the exit measure third, according to the roundup.

The next EY-IVCA roundup will show whether September's 11-deal pace and $1.1 billion investment persist after Q3 2026. Whether healthcare holds No. 2 will depend in part on whether future transactions approach the $1.4 billion scale of KKR's Medicover India deal.